Bioinformatics Market: Transforming Life Sciences with AI & NGS Innovation

1. Bioinformatics Market Poised for 13.4% Growth: AI Integration and Genomics Research Drive $31.71

2. Global Bioinformatics Market –2024-2031 Meticulous Research®, a leading global market research company, published a research report titled ‘Bioinformatics Market Size, Share, Forecast, & Trends Analysis By Solutions & Services (Knowledge Management, Sequence Analysis, Data Analysis) Application (Genomics, Metabolomics, Transcriptomics) Industry (Health, Agriculture) – Global Forecast to 2031. According to this latest publication from Meticulous Research®, the bioinformatics market is expected to grow at a CAGR of 13.4% from 2024 to reach $31.71 billion by 2031. The growth of this market is driven by the growth of the biotech and pharmaceutical industries, initiatives supporting genomics research, and the rising need to develop novel drugs/drug molecules. However, interoperability limitations in bioinformatics analytical platforms due to multiple data types restrain the growth of this market. Primary Growth Catalysts The bioinformatics market's push toward $31.71 billion is driven by the expansion of the biotech and pharmaceutical industries, increased support for genomics research, and the growing need for novel drug development. This has created a strong ecosystem where computational power and biological expertise converge to address complex scientific challenges. The digital transformation of healthcare is accelerating adoption, as pharmaceutical companies, research institutions, and clinical labs move beyond traditional wet-lab methods. The need to analyze massive datasets from genomics, clinical trials, and population health is fueling demand for advanced bioinformatics solutions. AI Integration: The Game Changer Artificial intelligence is changing bioinformatics by improving gene prediction, variant calling, and comparative genomics. Deep learning models like CNNs and RNNs excel in sequence analysis, including predicting DNA motifs and transcription factor binding sites. AI is dramatically lowering medication development durations by finding potential molecules and predicting their behavior. It also allows for quick investigation of protein structures, gene connections, and disease biomarkers. These advancements areespecially significant in oncology, where AI can identify therapeutic targets and predict treatment outcomes with increased speed and precision. Regional Growth Hotspots Page 1 of 3 © Meticulous Research| sales@meticulousresearch.com

3. Global Bioinformatics Market –2024-2031 North America is expected to account for 44.5% of the global bioinformatics market in 2024, owing to strong government support for genomics research, increased investment from pharmaceutical and biopharmaceutical companies, and increasing adoption of precision cancer medicine as cancer prevalence rises. Asia-Pacific is predicted to expand the quickest, at a CAGR of 14.3% from 2024 to 2031. This rise is being driven by the expansion of the pharmaceutical and biotechnology industries, increased genomics research, and favorable government policies fostering bioinformatics tool development and agricultural genetic engineering. Europe also offers enormous prospects, thanks to legal frameworks that encourage precision medicine, large public financing in life sciences, and a strong emphasis on data privacy and compliance, which is driving demand for advanced bioinformatics platforms. Next-Generation Sequencing: The Data Engine Advances in next generation sequencing analytics powered by sophisticated computational tools are central to market growth projections. The next generation sequencing market size to rise from USD 8.44 in 2023 is to hit USD 73.47 billion in 2034, increasing at a CAGR of 21.74% between 2024 and 2034. NGS technologies are generating unprecedented volumes of genomic data, creating both opportunities and challenges for bioinformatics providers. The ability to sequence entire genomes quickly and affordably has democratized genomics research, but it has also created a massive data processing bottleneck that only sophisticated bioinformatics solutions can address. This technology is enabling population-scale genomic studies, rare disease research, and agricultural genomics applications that were previously impossible. The resulting data explosion is driving demand for cloud-based bioinformatics platforms capable of handling petabyte-scale datasets. Navigating Market Challenges While the bioinformatics market is projected to reach $31.71 billion by 2031, several challenges may hinder growth. These include the complexity of biological data interpretation, high software and infrastructure costs, a severe shortage of skilled professionals, and lack of standardization— particularly in resource-limited settings. Educational institutions are not producing enough experts to meet demand, and concerns over data privacy, security, and regulatory compliance further Page 2 of 3 © Meticulous Research| sales@meticulousresearch.com

4. Global Bioinformatics Market –2024-2031 complicate global expansion. Overcoming these barriers is essential to realizing the market's full potential. Key Players The key players operating in the bioinformatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Dassault Systèmes SE (France), Eurofins Genomic LLC (Germany), Revvity, Inc. (U.S.), Azenta, Inc. (U.S.), and DNAnexus, Inc. (U.S.). Download Sample Report Here- @ https://www.meticulousresearch.com/download-sample- report/cp_id=5731 Contact Us: Meticulous Research® Email-sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn-https://www.linkedin.com/company/meticulous-research Page 3 of 3 © Meticulous Research| sales@meticulousresearch.com